Geipel, A.* et al. Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine. Antivir. Ther. (Lond.) 20, 779-787 (2016)
Corzillius, M.* et al. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV. Antivir. Ther. (Lond.) 9, 27-36 (2004)